DICOM PS3.17 2021e - Explanatory Information

WWWW.5 Complete Prostate Imaging Report SR Document

This example contains all of the components for a complete report.

Table WWWW.5-1. Complete Prostate Imaging Report SR Document

Node

Code Meaning of Concept Name

Code Meaning or Example Value

TID

1

Multiparametric magnetic resonance imaging of prostate

TID 4300

1.1

Language of Content Item and Descendants

English

TID 1204

1.2

Observer Type

Person

TID 1001

1.3

Person Observer Name

Smith^John

TID 1003

1.4

Subject name

Jackson^Paul

TID 1007

1.5

Subject ID

S98765432

TID 1007

1.6

Reporting System

PI-RADS v2.0

TID 4300

1.7

Image Library

TID 1600

1.7.1

Image Library Group

TID 1600

1.7.1.1

Modality

MR

TID 1602

1.7.1.2

Magnetic field strength

3 T

TID 1606

1.4.1.3

MR coil

Endorectal

TID 1606

CID 6349

1.7.1.4

MR signal intensity

T2 Weighted MR Signal Intensity

TID 1606

CID 6311

1.7.1.5

Cross-sectional scan plane orientation

Axial

TID 1606

CID 6312

1.7.1.6

IMAGE

TID 1601

1.7.1.n

IMAGE

TID 1601

1.7.2

Image Library Group

TID 1600

1.7.2.1

Modality

MR

TID 1602

1.7.2.2

Magnetic field strength

3 T

TID 1606

1.7.2.3

MR coil

Endorectal

TID 1606

CID 6349

1.7.2.4

MR signal intensity

Diffusion weighted

TID 1606

CID 6311

1.7.2.5

Cross-sectional scan plane orientation

Axial

TID 1606

CID 6312

1.7.2.6

Source image diffusion b-value

50 s/mm2

TID 1606

1.7.2.7

Source image diffusion b-value

400 s/mm2

TID 1606

1.7.2.8

Source image diffusion b-value

800 s/mm2

TID 1606

1.7.2.9

Source image diffusion b-value

1400 s/mm2

TID 1606

1.7.2.7

IMAGE

TID 1601

1.7.2.n

IMAGE

TID 1601

1.7.3

Image Library Group

TID 1600

1.7.3.1

Modality

MR

TID 1602

1.7.3.2

Magnetic field strength

3 T

TID 1606

1.7.3.3

MR coil

Endorectal

TID 1606

CID 6349

1.7.3.4

MR signal intensity

Dynamic Contrast-Enhanced Acquisition

TID 1606

CID 6311

1.7.3.5

Cross-sectional scan plane orientation

Axial

TID 1606

CID 6312

1.7.3.6

Prostate DCE temporal resolution

10 s

TID 1608

1.7.3.7

IMAGE

TID 1601

1.7.3.n

IMAGE

TID 1601

1.8

General Relevant Patient Information

TID 9007

CID 6327

1.8.1.1

Indicated Problem

Elevated Prostate Specific Antigen

TID 9007

CID 6327

1.8.2

Genitourinary History

TID 4301

1.8.2.1

Diagnostic procedure

TID 4301

1.8.2.1.1

Blood lab measurements

TID 1700

CID 6352

1.8.2.1.1.1

Sampling DateTime

19860101120101-0400

TID 1700

1.8.2.1.1.2

Prostate Cancer Antigen Measurement

12.1 ng/mL

TID 1700

TID 300

1.9

Prostate MRI relevant procedure information

TID 4300

1.9.1

Contrast administered

Gadobutrol

TID 3106

CID 3409

CID 12

1.9.1.1

Route of administration

Intra-arterial route

TID 3106

CID 11

1.9.1.2

Volume administered

10 mL

TID 3106

CID 3410

1.9.1.3

Rate of administration

2 ml/s

TID 3106

CID 3410

1.9.2

Endorectal coil used

No

TID 4300

CID 231

1.10

Imaging study quality

TID 1701

1.10.1

Quality Assessment

Usable - Meets the quality control standard

TID 1701

CID 6044

1.10.2

Quality Control Standard

PI-RADS 2.0 prostate MRI acquisition requirements

TID 1701

CID 6353

1.10.3

Imaging Series Quality

TID 1701

1.10.3.1

Series Instance UID

TID 1701

1.10.3.2

Quality Assessment

Usable - Meets the quality control standard

TID 1701

CID 6044

1.10.3.3

Quality Control Standard

Institutionally defined quality control standard

TID 1701

CID 6326

1.10.3.4

Quality Finding

Distortion artifact in the area of interest

TID 1701

CID 6318

1.11

Prostate Imaging Findings

TID 4302

1.11.1

Overall Prostate Finding

TID 4303

1.11.1.1

Tracking Identifier

"Prostate"

TID 4303

1.11.1.2

Tracking Unique Identifier

2.999.1

TID 4303

1.11.1.3

Finding

Entire

TID 4303

1.11.1.4

Finding site

Prostate

TID 4303

1.11.1.5

Measurement Group

TID 1501

1.11.1.5.1

Height

5 mm

TID 300

CID 7470

1.11.1.5.1.1

Source

SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment

TID 320

1.11.1.5.1.1.1

(none)

IMAGE - MR image #1

TID 320

1.11.1.5.2

Width

4 mm

TID 300

CID 7470

1.11.1.5.2.1

Source of Measurement

SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment

TID 320

1.11.1.5.2.1.1

(none)

IMAGE - MR image #2

TID 320

1.11.1.5.3

Length

4 mm

TID 300

CID 7470

1.11.1.5.3.1

Source

SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment

TID 320

1.11.1.5.3.1.1

(none)

IMAGE - MR image #3

TID 320

1.11.1.6

Peripheral zone

TID 4303

CID 6300

1.11.1.6.1

Signal characteristics

Heterogeneous

TID 4303

CID 6334

CID 6344

1.11.1.6.2

Signal characteristics

Slightly heterogeneous high signal

TID 4303

CID 6334

1.11.1.7

Transition zone

TID 4303

CID 6300

1.11.1.7.1

Signal characteristics

Heterogeneous

TID 4303

CID 6334

CID 6344

1.11.2

Localized Prostate Finding

TID 4304

1.11.2.1

Tracking Identifier

"Lesion 1"

TID 4304

1.11.2.2

Tracking Unique Identifier

2.999.2

TID 4304

1.11.2.3

Finding

Index lesion

TID 4304

CID 6337

1.11.2.4

Finding Site

Right anterior middle peripheral zone of prostate

TID 4304

CID 6300

1.11.2.5

Measurement Group

TID 1501

1.11.2.5.1.1

Length

1.1 cm

TID 300

CID 7470

1.11.2.5.1.1.1

Source

SCOORD GraphicType POLYLINE with two coordinates, the beginning and end of a line segment

TID 300

1.11.2.5.1.1.1.1

(none)

IMAGE - MR image #4

TID 1410

1.11.2.6

PI-RADS Localized Abnormality Assessment

TID 4306

1.11.2.6.1

Index Lesion

Yes

TID 4306

CID 231

1.11.2.6.2

PI-RADS T2WI Lesion Assessment

TID 4306

1.11.2.6.2.1

PI-RADS T2WI Lesion Assessment Category

PI-RADS 5 - T2WI PZ Very high

TID 4306

CID 6329

1.11.2.6.2.2

Signal characteristics

Homogeneous

TID 4306

????

????

1.11.2.6.2.3

Signal characteristics

Hypointense

TID 4306

????

????

1.11.2.6.3

PI-RADS DWI Lesion Assessment

TID 4306

1.11.2.6.3.1

PI-RADS DWI Lesion Assessment Category

PI-RADS 5 - DWI Very high

TID 4306

CID 6331

1.11.2.6.3.2

Signal characteristics

Hyperintense

TID 4306

????

????

1.11.2.6.3.3

Status of extraprostatic extension of nodal tumor

Present

TID 4306

????

????

1.11.2.6.4

PI-RADS DCE Lesion Assessment

TID 4306

1.11.2.6.4.1

PI-RADS DCE Lesion Assessment Category

PI-RADS DCE +ve

TID 4306

CID 6332

1.11.2.6.5

PI-RADS Lesion Assessment Category

PI-RADS 5 - Very high (lesion)

TID 4306

CID 6328

1.11.3

PI-RADS Overall Assessment Category

PI-RADS 5 - Very high

TID 4302

CID 6325


DICOM PS3.17 2021e - Explanatory Information